Concepedia

Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression

Robert A. Hodgson, Rosalia Bertorelli, Geoffrey B. Varty, Jean E. Lachowicz, A Forlani, Silva Fredduzzi, Mary Cohen-Williams, Guy A. Higgins, Francesco Impagnatiello, Elisa Nicolussi,

Journal of Pharmacology and Experimental Therapeutics · 2009 · 149 citations · 30 references

DOI

Concepts

References

30

Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system

Diane L. Rosin, Anna Robeva, Robin L. Woodard et al. · The Journal of Comparative Neurology · 1998 · 382 citations

, , +13

Adenosine A<sub>2A</sub> Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys

Tomoyuki Kanda, Michael Jackson, Lance A. Smith et al. · Annals of Neurology · 1998 · 356 citations

, , +16

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

Gianluigi Tanda, Ezio Carboni, Roberto Frau et al. · Psychopharmacology · 1994 · 321 citations

, , +16

Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease

Erika Driver‐Dunckley, Johan Samanta, Mark Stacy · Neurology · 2003 · 312 citations

, , +13

Randomized trial of the adenosine A <sub>2A</sub> receptor antagonist istradefylline in advanced PD

Robert A. Hauser, Jean Hubble, Daniel D. Truong · Neurology · 2003 · 297 citations

, , +16